Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Current Medicinal Chemistry|August 25, 2011
New strategies in the discovery of novel non-camptothecin topoisomerase I inhibitorsChunquan Sheng, Zhenyuan Miao, Wannian ZhangMedchemcomm|August 16, 2018
Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: a novel approach to activate Nrf2 functionChunlin Zhuang, Zhongli Wu, Chengguo Xing, et al.Future Medicinal Chemistry|June 11, 2025
Recent developments in matrine as a versatile molecular scaffold in small molecule drug discoveryWei Li, Hongling Wang, Wannian Zhang, et al.Current Medicinal Chemistry|February 19, 2014
Updated research and applications of small molecule inhibitors of Keap1-Nrf2 protein-protein interaction: a reviewChunlin Zhuang, Zhenyuan Miao, Chunquan Sheng, et al.Chemical Society Reviews|August 7, 2015
State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitorsChunquan Sheng, Guoqiang Dong, Zhenyuan Miao, et al.Chemical Society Reviews|August 27, 2015
Correction: State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitorsChunquan Sheng, Guoqiang Dong, Zhenyuan Miao, et al.Chemistry & Biodiversity|December 17, 2010
Chemical composition and antidiabetic activity of Opuntia Milpa Alta extractsChuan Luo, Wannian Zhang, Chunquan Sheng, et al.Journal of Medicinal Chemistry|October 15, 2010
Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agentsGuoqiang Dong, Chunquan Sheng, Shengzheng Wang, et al.Chemical Reviews|May 11, 2017
Chalcone: A Privileged Structure in Medicinal ChemistryChunlin Zhuang, Wen Zhang, Chunquan Sheng, et al.Journal of Medicinal Chemistry|June 28, 2022
Homobivalent, Trivalent, and Covalent PROTACs: Emerging Strategies for Protein DegradationJianyu Yan, Tengfei Li, Zhenyuan Miao, et al.Pageof 10